Stay updated with breaking news from Polysciences Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The global polyethyleneimine market is expected to grow by USD 60.75 million, accelerating at a CAGR of 2.68% between 2021 and 2026, according...
Special Note Regarding Forward-Looking Statements Certain statements in this Report contain forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of... | May 13, 2022
/PRNewswire/ -- The cytology market size is set to grow by USD 1.98 billion from 2021 to 2026, at a CAGR of 6.98% according to the latest research report from...
/PRNewswire/ -- The cytology market size is set to grow by USD 1.98 billion from 2021 to 2026, at a CAGR of 6.98% according to the latest research report from...
AIM ImmunoTech (NYSE:AIM – Get Rating) and Icosavax (NASDAQ:ICVX – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability and risk. Institutional and Insider Ownership 15.6% of AIM ImmunoTech shares are […]